## Core Concept
Bioavailability of a drug refers to the fraction of an administered dose of unchanged drug that reaches the systemic circulation and is one of the principal pharmacokinetic properties of drugs. It is a critical parameter in determining the efficacy and safety of drugs. Bioavailability can be influenced by factors such as the route of administration, formulation of the drug, and individual patient characteristics.

## Why the Correct Answer is Right
The correct answer is related to the definition and factors affecting bioavailability. Bioavailability is indeed affected by the route of administration, with intravenous (IV) administration having a bioavailability of 100% since the drug is directly introduced into the systemic circulation. Oral bioavailability can be less than 100% due to first-pass metabolism. However, without the specific statements provided for A, B, C, and D, we focus on general principles: bioavailability is crucial for understanding drug efficacy and safety, and it can vary significantly between drugs and between individuals.

## Why Each Wrong Option is Incorrect
Given that the specific details of options A, B, C, and D are not provided, let's discuss general incorrect statements regarding bioavailability:
- **Option A:** If a statement claims bioavailability is only relevant for oral drugs, it would be incorrect because bioavailability is a concern for any drug not administered intravenously, including drugs given intramuscularly, subcutaneously, transdermally, or rectally.
- **Option B:** A statement suggesting bioavailability does not affect drug efficacy or safety would be incorrect. Bioavailability directly impacts the concentration of drug achieved in the bloodstream, which in turn affects both efficacy and safety.
- **Option C:** If a statement implies bioavailability is constant for a given drug across all patients, it would be incorrect. Bioavailability can vary between individuals due to factors like genetic differences in metabolism, age, and concurrent illnesses.
- **Option D:** Without specifics, if one assumes D might relate to a correct principle of bioavailability (like it being less than 100% for many non-IV drugs due to first-pass effect), then any statement contradicting established pharmacokinetic principles would be incorrect.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the **bioavailability of a drug administered intravenously is 100%**, as it directly enters the systemic circulation. This is a crucial concept in pharmacokinetics and pharmacodynamics, as it serves as a reference point for comparing the bioavailability of drugs administered via other routes.

## Correct Answer: C.